Document Preview Unavailable
Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study
Singh, Ravi Shankar P; Pradhan, Vivek; Roberts, Erika S; Scaramozza, Matthew; Kieras, Elizabeth; et al. Clinical and Translational Science Vol. 14, Iss. 2, (Mar 2021): 671-682.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library